PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 11 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Juglone extracted from P. fraxinifolia was evaluated in rats with acetic acid-induced colitis; it possesses anti-inflammatory and antioxidant characteristics [PMID:37936449]
Juglone and P. fraxinifolia methanolic extract demonstrated cytotoxic and apoptosis effects on human prostate cancer cell lines (PC3 and DU145) [PMID:31555025]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 30906242 (2019) — The genus Juglanconis (Diaporthales) on Pterocarya. · Mycological progress
- 2.PMID: 37936449 (2023) — Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. · Anti-inflammatory & anti-allergy agents in medicinal chemistry
- 3.PMID: 41419494 (2025) — Characterization of the chloroplast genome of a relict tree, Pterocarya fraxinifolia (Juglandaceae), and its comparative analysis. · Scientific reports
- 4.PMID: 38283971 (2023) — Salicylic acid alleviates the effects of cadmium and drought stress by regulating water status, ions, and antioxidant defense in Pterocarya fraxinifolia. · Frontiers in plant science
- 5.PMID: 15303703